IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 122 filers reported holding IVERIC BIO INC in Q4 2020. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,811,884 | +207.5% | 223,993 | +90.1% | 0.01% | +200.0% |
| Q1 2023 | $2,866,074 | +26.8% | 117,800 | +11.6% | 0.00% | +50.0% |
| Q4 2022 | $2,260,104 | +54.7% | 105,563 | +29.6% | 0.00% | 0.0% |
| Q3 2022 | $1,461,000 | +106.9% | 81,465 | +11.1% | 0.00% | +100.0% |
| Q2 2022 | $706,000 | -31.1% | 73,355 | +20.6% | 0.00% | 0.0% |
| Q1 2022 | $1,024,000 | +10.5% | 60,841 | +9.7% | 0.00% | – |
| Q4 2021 | $927,000 | +35.7% | 55,443 | +31.9% | 0.00% | – |
| Q3 2021 | $683,000 | +271.2% | 42,029 | +43.7% | 0.00% | – |
| Q2 2021 | $184,000 | -51.5% | 29,251 | -52.2% | 0.00% | – |
| Q1 2021 | $379,000 | -55.6% | 61,155 | -50.5% | 0.00% | – |
| Q4 2020 | $854,000 | +669.4% | 123,574 | +281.8% | 0.00% | – |
| Q1 2020 | $111,000 | -86.0% | 32,363 | -65.0% | 0.00% | -100.0% |
| Q4 2019 | $794,000 | – | 92,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |